Adobe Sign renewed for a year at Cell and Gene Therapy Catapult
- Cell and Gene Therapy Catapult
- London
- Below threshold - without competition
- 25 September 2026 to 24 September 2027
Cell and Gene Therapy Catapult has renewed its licence and support for Adobe Sign, its electronic signature software. The catapult uses it across the organisation to approve contracts and other corporate papers. The catapult describes the software as business-critical.
The catapult awarded the £17,400 renewal directly to Adobe in September 2026, without a competition. The licence runs for 12 months, to September 2027.
Contract ends September 2027
- What
- Electronic signature software
- Supplier
- Adobe
- Value
- £17,400
- How it was bought
- Below threshold - without competition
- Dates and next
- Sep 2026 to Sep 2027